Join
Live feed
·
INSIDERFilingvia Quantisnow
Lexeo Therapeutics Inc. logo

Chief Development Officer See Tai Sandi was granted 10,890 shares and sold $34,767 worth of shares (3,888 units at $8.94), increasing direct ownership by 12% to 65,862 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LXEO (Lexeo Therapeutics Inc.) and more on Quantisnow.